Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation

被引：28
|
作者：
Torre-Cisneros, J
De la Mata, M
Pozo, JC
Serrano, P
Briceño, J
Solórzano, G
Miño, G
Pera, C
Sánchez-Guijo, P
机构：
[1] Hosp Univ Reina Sofia, Infect Dis Sect, Cordoba, Spain
[2] Hosp Univ Reina Sofia, Liver Transplantat Unit, Cordoba, Spain
来源：
CLINICAL INFECTIOUS DISEASES | 1999年 / 29卷 / 04期
关键词：
D O I：
10.1086/520432
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We conducted a prospective, randomized clinical trial among liver transplant patients to assess the efficacy and safety of weekly sulfadoxine/pyrimethamine compared with daily trimethoprimsulfamethoxazole in the prevention of Pneumocystis carinii pneumonia, The studied drugs were given during 6 months after transplantation. One hundred twenty patients were included. None of the 60 patients receiving weekly sulfadoxine/pyrimethamine developed Pneumocystis carinii pneumonia, whereas two cases (3%) developed among the 60 patients who received trimethoprimsulfamethoxazole. For both patients, the studied medication had been discontinued several weeks earlier because of adverse effects. No differences were observed in the incidence of adverse effects. We conclude that weekly sulfadoxine/pyrimethamine is as effective and safe as is daily trimethoprim-sulfamethoxazole in the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation.
引用
收藏
页码：771 / 774
页数：4
相关论文
共 50 条
  • [31] A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation
    C Colby
    SL McAfee
    R Sackstein
    DM Finkelstein
    JA Fishman
    TR Spitzer
    Bone Marrow Transplantation, 1999, 24 : 897 - 902
  • [32] CLINDAMYCIN PRIMAQUINE VERSUS TRIMETHOPRIM-SULFAMETHOXAZOLE AS PRIMARY THERAPY FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN AIDS - A RANDOMIZED, DOUBLE-BLIND PILOT TRIAL
    TOMA, E
    FOURNIER, S
    DUMONT, M
    BOLDUC, P
    DESCHAMPS, H
    CLINICAL INFECTIOUS DISEASES, 1993, 17 (02) : 178 - 184
  • [33] Impact of Very Low-Dose Trimethoprim-Sulfamethoxazole on Serum Creatinine after Renal Transplantation: A Retrospective Study
    Yamanaga, Shigeyoshi
    Tanaka, Kosuke
    Kinoshita, Kohei
    Kaba, Akari
    Fujii, Mika
    Ogata, Masatomo
    Hidaka, Yuji
    Kawabata, Chiaki
    Toyoda, Mariko
    Uekihara, Soichi
    Kashima, Masayuki
    Miyata, Akira
    Inadome, Akito
    Yokomizo, Hiroshi
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (06) : 1757 - 1761
  • [34] Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial
    Sohani, Zahra N.
    Butler-Laporte, Guillaume
    Aw, Andrew
    Belga, Sara
    Benedetti, Andrea
    Carignan, Alex
    Cheng, Matthew P.
    Coburn, Bryan
    Costiniuk, Cecilia T.
    Ezer, Nicole
    Gregson, Dan
    Johnson, Andrew
    Khwaja, Kosar
    Lawandi, Alexander
    Leung, Victor
    Lother, Sylvain
    MacFadden, Derek
    McGuinty, Michaeline
    Parkes, Leighanne
    Qureshi, Salman
    Roy, Valerie
    Rush, Barret
    Schwartz, Ilan
    So, Miranda
    Somayaji, Ranjani
    Tan, Darrell
    Trinh, Emilie
    Lee, Todd C.
    McDonald, Emily G.
    BMJ OPEN, 2022, 12 (07):
  • [35] Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim-sulfamethoxazole: lessons from an observational cohort study
    Creemers-Schild, Dina
    Kroon, Frank P.
    Kuijper, Ed. J.
    de Boer, Mark G. J.
    INFECTION, 2016, 44 (03) : 291 - 299
  • [36] Outcomes of low-dose trimethoprim-sulfamethoxazole treatment in patients with non-HIV pneumocystis pneumonia: A nationwide Japanese retrospective cohort study
    Taniguchi, Jumpei
    Aso, Shotaro
    Jo, Taisuke
    Matsui, Hiroki
    Fushimi, Kiyohide
    Yasunaga, Hideo
    INFECTIOUS DISEASES NOW, 2024, 54 (08):
  • [37] PROPHYLAXIS OF RECURRENT URINARY-TRACT INFECTION IN FEMALE PATIENTS - EFFICACY OF LOW-DOSE, THRICE-WEEKLY THERAPY WITH TRIMETHOPRIM-SULFAMETHOXAZOLE
    HARDING, GKM
    BUCKWOLD, FJ
    MARRIE, TJ
    THOMPSON, L
    LIGHT, RB
    RONALD, AR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 242 (18): : 1975 - 1977
  • [38] A Four-Center Retrospective Study of the Efficacy and Toxicity of Low-Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Pneumonia in Patients without HIV Infection
    Kosaka, Makoto
    Ushiki, Atsuhito
    Ikuyama, Yuichi
    Hirai, Kazuya
    Matsuo, Akemi
    Hachiya, Tsutomu
    Hanaoka, Masayuki
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (12)
  • [39] ORAL TRIMETHOPRIM-SULFAMETHOXAZOLE (TM-SMX) VS INHALED PENTAMIDINE (P) FOR PREVENTION OF PNEUMOCYSTIS PNEUMONIA (PCP) AFTER RENAL-TRANSPLANTATION
    PEDAGOGOS, E
    NICHOLLS, K
    WILSON, J
    WALKER, R
    BECKER, G
    KIDNEY INTERNATIONAL, 1994, 46 (03) : 922 - 922
  • [40] Comparison of High-Dose versus Low-Dose Trimethoprim-Sulfamethoxazole for Treating Pneumocystis jirovecii Pneumonia among Hemodialysis Patients: A Nationwide Database Study in Japan
    Shuto, Hisayuki
    Omori, Shota
    Hiramatsu, Kazufumi
    Kadota, Jun-ichi
    Fushimi, Kiyohide
    Komiya, Kosaku
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (18)
12345